Minireviews
Copyright ©The Author(s) 2023.
World J Hepatol. Aug 27, 2023; 15(8): 954-963
Published online Aug 27, 2023. doi: 10.4254/wjh.v15.i8.954
Table 3 Alcohol-associated hepatitis prognostic scores advantages and limitations
Clinical score
Components
Advantages
Limitations
MELDINR, bilirubin (total), creatinine, sodiumMELD or MELD-Na ≥ 20 predicts high mortality at 30 d, consider corticosteroid therapy(1) Mortality overestimation with elevated creatinine levels; (2) interpersonal variability of creatinine levels; (3) extrahepatic causes of sodium fluctuations; and (4) does not account for markers of AAH complications other than kidney and liver failure
Maddrey discriminant functionPT (measured and control), bilirubin (total)MDF ≥ 32 predicts high mortality at 30 d, consider corticosteroid therapy. Oldest, most commonly used score(1) AKI and other AAH complications not reflected in MDF; (2) PT use instead of INR; and (3) low specificity
GAHSAge, WBC, BUN, bilirubin, PT (measured and control)GAHS ≥ 9 is in favor of high mortality, helpful for selecting candidates for steroid treatment(1) Only studied on the British population; and (2) lower sensitivity for short-term mortality compared to MELD/MDF
ABICAge, Bilirubin, INR, PT (measured and control)Score < 6.71 has high negative predictive value to detect patients with low risk(1) Not used for deciding on steroid initiation; and (2) low accuracy for predicting mortality in severe group
Lille scoreAge, bilirubin (initial, and day 4 OR day 7), albumin, creatinine, and PTLille score ≤ 0.45 at day 7 (or 4) implies good response to corticosteroids(1) Complex to calculate; (2) uses PT instead of INR; and (3) bias secondary to elevated creatinine levels and interpersonal variability of creatinine
Alcoholic hepatitis histological scoreHistologic features of liver injuryCan be combined with clinical prognostic scores for more accurate mortality risk stratification(1) Requires liver biopsy (invasive); and (2) static